Good morning ☀️, leader of the next generation.

We will talk about agents. AI agents.

They will change the way how we do business, how we interract and even how we do our everyday lives.

Agents will build business.

Agents will organize your day.

Agents will fill up your fridge.

I will let that sit in here for a while, so we can imagine and build the future together one agent at a time...

⚡ WHAT'S AT STAKE TODAY ⚡

1. 🧠🔬 Max Hodak's Science Corp. is preparing to place its first sensor in a human brain
2. 🤖💻 Google adds AI Skills to Chrome to help you save favorite workflows
3. 📱🔄 How vibe-coding app Anything is rebuilding after getting booted from the App Store twice
4. 🇮🇳🤖 Google brings its Gemini Personal Intelligence feature to India
5. 🏛️🤝 Anthropic co-founder confirms the company briefed the Trump administration on Mythos
6. 📈💭 Anthropic's rise is giving some OpenAI investors second thoughts
7. 📊🏢 Three-quarters of AI's economic gains are being captured by just 20% of companies – with the leading companies focused on growth, not just productivity: PwC
8. 🏭📈 NVIDIA's AI Factory Vision: Can It Further Boost Data Center Growth?
9. 💰🤖 OpenAI has bought AI personal finance startup Hiro

Science Corp prepares groundbreaking biohybrid brain-computer interface for human trials

Max Hodak's Science Corp. is preparing to place its first sensor in a human brain

Science Corporation, led by former Neuralink co-founder Max Hodak, is preparing to make history by implanting its revolutionary biohybrid brain-computer interface in its first human patient. The startup has recruited Dr. Murat Günel, chair of Yale Medical School's Department of Neurosurgery, to spearhead this groundbreaking human trial.

Founded in 2021, Science recently closed a massive $230 million Series C funding round, pushing its valuation to $1.5 billion. While the company's most advanced product, PRIMA, focuses on restoring vision for people with macular degeneration, Hodak's ultimate vision extends far beyond treating blindness.

What sets Science apart from competitors like Neuralink is its innovative biohybrid approach. Traditional brain-computer interfaces rely on metal electrodes that can cause brain damage over time, potentially undermining long-term performance. Science's solution combines lab-grown neurons with electronics, creating a more natural bridge between biology and technology.

"The idea of using natural connections through neurons and creating a biological interface between the electronics and the human brain is genius," Günel explained. This organic approach could revolutionize how we treat neurological conditions while opening doors to human enhancement possibilities.

The company's biohybrid sensor, developed by a 30-person research team led by Chief Science Officer Alan Mardinly, contains lab-grown neurons that can be stimulated with light pulses. These neurons are designed to naturally integrate with existing brain cells, forming seamless biological connections. Initial tests in mice proved the device's safety and effectiveness in 2024.

Unlike Neuralink's invasive approach, Science's sensor will rest on top of the brain rather than penetrating brain tissue directly. This less invasive placement, combined with the device's tiny size—520 recording electrodes packed into a pea-sized area—led the company to believe FDA approval won't be necessary for initial trials.

The first human trials will target patients already requiring major brain surgery, such as stroke victims needing skull removal to reduce brain swelling. In these cases, Günel plans to place the sensor on the cortex surface to evaluate its safety and brain activity monitoring capabilities.

If successful, the applications could be transformative. Early uses might include delivering gentle electrical stimulation to damaged brain or spinal cord cells to promote healing. More advanced applications could monitor neurological activity in brain tumor patients, providing early seizure warnings to caregivers.

Perhaps most exciting is the potential for treating progressive neurological diseases like Parkinson's. Current treatments include experimental brain cell transplants and deep brain stimulation, but neither reliably stops disease progression. Günel envisions the biohybrid system combining both approaches—electronics and biological components working together.

"In Parkinson's, we cannot stop the progression of the disease; in neurosurgery, all we are doing is putting an electrode to stop the tremors," Günel noted. "Whereas if you can really put the cells back in the brain, protect those circuits, there's a chance we can stop progression of the disease."

The team is currently developing prototypes and determining how to grow neuron cells for different therapeutic applications that meet medical standards. They're also engaging with medical ethics boards to prepare for human trials, though Günel admits it would be "optimistic" to expect trials to begin before 2027.

This breakthrough represents a significant leap forward in brain-computer interface technology, potentially offering hope to millions suffering from neurological conditions while laying groundwork for future human enhancement capabilities.

Chrome introduces Skills feature for reusable AI prompts

Google adds AI Skills to Chrome to help you save favorite workflows

Google is introducing Skills, a new AI feature for Chrome that lets users save and reuse favorite prompts across different web pages. Building on Gemini AI integration, Skills allows one-click access to commonly used AI tasks like finding vegan recipe substitutions or calculating macros.

Users can save prompts from chat history and access them using forward slash (/) or plus (+) buttons. Google is launching a Skills library with pre-programmed workflows for productivity, shopping, and budgeting. The feature rolls out today for Chrome desktop users with English (US) language settings.

🎙️ The Supercharged Podcast Is Growing

Real Conversations with the People Building the AI Future

The Supercharged Podcast is quickly becoming a space for real, unfiltered conversations about AI — beyond the hype, tools, and surface-level takes.

Each episode dives deep with founders, operators, and builders who are actively working with AI — or building AI-first companies — to uncover how it’s truly changing the way work gets done.

From strategy and systems to real-world execution, these conversations are practical, honest, and focused on what actually works — not just what sounds good.

OpenAI acquires Hiro Finance in talent-focused deal expanding fintech capabilities.

⚡ Let’s Make AI Actually Useful:
What Would Move the Needle in *Your* Industry?

AI has potential — but generic advice rarely helps.

What would be genuinely valuable for AI to do in your industry right now?

• Automate a painful workflow?
• Improve decision-making?
• Replace a manual process that wastes time?
• Help your team upskill faster?

Tell us what you’d want AI to handle — or where you feel stuck.

We’re using these insights to curate **industry-specific trainings, live webinars, and practical guidance** you can actually apply.